Steven Cohen’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94.3M Buy
+124,380
New +$94M 0.1% 223
2026
Q2
– Sell
-2,175
Closed -$1.48M – 4489
2026
Q1
$1.68M Sell
2,175
-260,352
-99% -$199M ﹤0.01% 2436
2025
Q4
$203M Buy
262,527
+61,028
+30% +$41.4M 0.23% 52
2025
Q3
$113M Buy
201,499
+58,391
+41% +$33M 0.19% 105
2025
Q2
$75.1M Buy
+143,108
New +$79.9M 0.15% 164
2024
Q3
– Sell
-22,871
Closed -$25.5M – 2279
2024
Q2
$24M Buy
+22,871
New +$22.2M 0.06% 356
2023
Q4
– Sell
-1,407
Closed -$1.16M – 2702
2023
Q3
$1.16M Buy
+1,407
New +$1.11M ﹤0.01% 1284
2021
Q3
– Sell
-188,700
Closed -$105M – 1206
2021
Q2
$105M Buy
+188,700
New +$95.6M 0.47% 35
2020
Q3
– Sell
-53,609
Closed -$33.4M – 1070
2020
Q2
$33.4M Buy
+53,609
New +$30.4M 0.22% 128
2019
Q4
– Sell
-440,940
Closed -$122M – 1204
2019
Q3
$122M Sell
440,940
-42,905
-9% -$12.7M 0.75% 19
2019
Q2
$151M Buy
+483,845
New +$161M 0.79% 17
2019
Q1
– Sell
-168,644
Closed -$63M – 1195
2018
Q4
$63M Buy
+168,644
New +$61.7M 0.31% 89
2018
Q3
– Sell
-27,700
Closed -$9.6M – 1190
2018
Q2
$9.6M Sell
27,700
-171,400
-86% -$53.6M 0.04% 451
2018
Q1
$68.6M Sell
199,100
-282,254
-59% -$98.2M 0.29% 95
2017
Q4
$181M Buy
+481,354
New +$195M 0.78% 15
2017
Q2
– Sell
-70,000
Closed -$27.1M – 978
2017
Q1
$27.1M Buy
+70,000
New +$25.9M 0.15% 186
2016
Q2
– Sell
-109,700
Closed -$39.5M – 849
2016
Q1
$39.5M Buy
+109,700
New +$45.2M 0.3% 81
2014
Q4
– Sell
-23,600
Closed -$8.51M – 774
2014
Q3
$8.51M Buy
23,600
+9,100
+63% +$3.05M 0.06% 307
2014
Q2
$4.1M Buy
+14,500
New +$4.3M 0.03% 487

Other funds holding REGN

Steven Cohen's REGN Position: Q3 2026 in Review

Steven Cohen opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 124,380 shares worth $94.3M. The stake represents 0.1% of the portfolio and ranks #223 among its holdings. This is a return to the name: Steven Cohen previously reported a position in REGN as recently as Q1 2026.

Steven Cohen first reported a position in REGN in Q2 2014 and has held it in 19 quarters since. The position peaked at $203M in Q4 2025. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Steven Cohen held 124,380 shares of Regeneron Pharmaceuticals worth $94.3M as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.1% of Steven Cohen's portfolio in Q3 2026, its #223 holding.
  • Steven Cohen first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 19 quarters since.
  • Steven Cohen's Regeneron Pharmaceuticals position peaked at $203M in Q4 2025.
  • 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.